Related Experiment Video
Updated: May 26, 2025
07:29
Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
1.4K
Extracellular vesicles and microRNAs in cancer progression
Nicola S Orefice1, Gianluca Petrillo2, Claudia Pignataro2
1Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Advances in Clinical Chemistry
|February 23, 2025
Summary
Extracellular vesicles (EVs) carrying microRNAs (miRNAs) are key in cancer cell communication, influencing tumor growth and spread. Studying EV-miRNA interactions offers new avenues for cancer diagnosis and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Extracellular vesicles (EVs) mediate intercellular communication by transporting bioactive molecules like microRNAs (miRNAs).
- MicroRNAs are crucial regulators of gene expression implicated in cancer development and progression.
- Dysregulated miRNA profiles in EVs contribute to cancer hallmarks and the tumor microenvironment.
Purpose of the Study:
- To elucidate the role of EV-mediated miRNA signaling in cancer pathogenesis.
- To highlight the potential of EV-derived miRNAs as biomarkers for cancer detection, prognosis, and treatment response.
Main Methods:
- Review of current literature on extracellular vesicles and microRNAs in cancer.
- Analysis of miRNA cargo within tumor-derived EVs.
- Investigation of EV-miRNA impact on recipient cells and the tumor microenvironment.
Main Results:
- Tumor-derived EVs transport specific miRNAs that modulate cancer cell proliferation, survival, angiogenesis, and metastasis.
- EV miRNAs influence the tumor microenvironment, promoting immune evasion and pre-metastatic niche formation.
- Altered EV miRNA profiles are associated with cancer hallmarks and progression.
Conclusions:
- EV-mediated miRNA signaling is a critical component of cancer pathogenesis.
- EV-derived miRNAs hold significant promise as biomarkers for early cancer detection and monitoring treatment efficacy.
- Targeting EV-miRNA pathways presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
01:22MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K